Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meeting20-09-2022
20-09-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 32,500 Equity shares under ESOP15-09-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings12-09-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings09-09-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings06-09-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate
Directors'' retirement by rotation01-09-2022
Gland Pharma Ltd - 543245 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gland Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-08-2022
Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Result and Consolidated Scrutinizer''s Report of 44th Annual General Meeting30-08-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings30-08-2022
Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 44th Annual General Meeting of the Company30-08-2022